Get the Stockscreener App
3.01
5.35%
-0.17
Pre-market:
3.01
Sophia Genetics Sa stock is traded at $3.01, with a volume of 58,491.
It is down -5.35% in the last 24 hours and down -13.75% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$3.18
Open:
$3.13
24h Volume:
58,491
Relative Volume:
0.65
Market Cap:
$203.41M
Revenue:
$64.49M
Net Income/Loss:
$-71.40M
P/E Ratio:
-2.7615
EPS:
-1.09
Net Cash Flow:
$-52.00M
1W Performance:
-8.79%
1M Performance:
-13.75%
6M Performance:
-18.21%
1Y Performance:
-7.10%
1-Day Range:
$2.96
$3.24
1-Week Range:
$2.92
$3.48
52-Week Range:
$2.58
$4.92
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
3.01 | 214.90M | 64.49M | -71.40M | -52.00M | -1.09 |
|
VEEV
Veeva Systems Inc
|
276.96 | 46.10B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
60.82 | 10.54B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
61.83 | 12.48B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.46 | 8.05B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
34.48 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
How to recover losses in SOPHiA GENETICS SA stockSteady Return Plan Based on Data Analysis - Newser
SOPHiA GENETICS SA Recovery Gathers Momentum on Chart SignalsAI Forecast for Trending Stocks Indicates Upside - beatles.ru
Is SOPHiA GENETICS SA stock bottoming outFree Swing Trading Plan With Smart Signals - Newser
Using Bollinger Bands to evaluate SOPHiA GENETICS SALong-Term Trend Tracking and Signal Summary - Newser
Why SOPHiA GENETICS SA stock attracts strong analyst attentionFree Fast Return Equity Trade Forecast - Newser
When is the best time to exit SOPHiA GENETICS SAMulti-Bagger Detection with Trend Tools - Newser
Forecasting SOPHiA GENETICS SA price range with options dataFree AI Trading Suggestions With Accuracy Focus - Newser
Predicting SOPHiA GENETICS SA trend using moving averagesPrice Forecast Based on AI Analysis - Newser
Advanced analytics toolkit walkthrough for SOPHiA GENETICS SATrend Following Ideas with Volume Confirmation - Newser
Using Ichimoku Cloud for SOPHiA GENETICS SA technicalsFree Trade Setups With Clear Risk Limits - Newser
Intraday pattern recognizer results for SOPHiA GENETICS SAFree AI Forecast for Trending Stocks - Newser
Analysts Are Updating Their SOPHiA GENETICS SA (NASDAQ:SOPH) Estimates After Its Second-Quarter Results - simplywall.st
Automated trading signals detected on SOPHiA GENETICS SAMarket Correction Proof Stock Screening Analysis - Newser
SOPHiA GENETICS S.A. (NASDAQ:SOPH) Q2 2025 Earnings Call Transcript - Insider Monkey
Visual trend scoring systems applied to SOPHiA GENETICS SAFree Entry Zone Strategy for Consistent Profit - Newser
SOPHiA GENETICS SA: Positive Earnings Call Highlights - TipRanks
Sophia Genetics SA (SOPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
SOPHiA GENETICS Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
SOPHiA GENETICS reaffirms $72M–$76M 2025 revenue guidance as AstraZeneca deal drives BioPharma outlook - MSN
SOPHiA GENETICS Reports Strong Q2 2025 Growth - TipRanks
Will SOPHiA GENETICS SA price bounce be sustainableBuy Zone Strategy with Pattern Recognition - Newser
Sophia Genetics stock price target raised to $6 at BTIG on growth outlook - Investing.com Nigeria
Sophia Genetics stock price target raised to $6 at BTIG on growth outlook By Investing.com - Investing.com South Africa
Transcript : SOPHiA GENETICS SA, Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
SOPHiA GENETICS SA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Short Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 123.8% - Defense World
Sophia Genetics SA reports results for the quarter ended June 30Earnings Summary - TradingView
SOPHiA GENETICS Reports Financial Results for Mid-2025 - TipRanks
SOPHiA GENETICS Reports Second Quarter 2025 Results - PR Newswire
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes - PR Newswire
What candlestick patterns are forming on SOPHiA GENETICS SAMomentum Entry Alerts with Risk Control - Newser
SOPHiA GENETICS SA Earnings Report Breakdown: What Investors Should KnowPredictive AI Signals for Short-Term Trading - Newser
Sophia Genetics SA (SOPH) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Is SOPHiA GENETICS SA a good long term investmentAchieve breakthrough profits with expert advice - Jammu Links News
What analysts say about SOPHiA GENETICS SA stockInvest confidently with professional market insights - Jammu Links News
What institutional investors are buying SOPHiA GENETICS SA stockAchieve consistent profits with smart trading - Jammu Links News
SOPHiA GENETICS (SOPH) Projected to Post Earnings on Tuesday - Defense World
Should I hold or sell SOPHiA GENETICS SA stock in 2025Stay informed with expert market forecasts - Jammu Links News
Is it the right time to buy SOPHiA GENETICS SA stockCapitalize on market shifts before others do - Jammu Links News
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
1.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):